What’s the typical Rinvoq (upadacitinib) cost per year?
Rinvoq pricing depends on several factors, especially the country, the exact dose (e.g., 15 mg vs 30 mg), the quantity dispensed, and whether insurance covers the drug. The provided information here doesn’t include a specific annual price figure, so a precise “cost per year” number can’t be calculated from the details available.
How to find Rinvoq’s per-year price for your dose and country
To get an accurate annual cost estimate, you usually need:
- Your country (U.S. pricing is different from other markets).
- Your prescribed dose and dosing frequency (Rinvoq is taken once daily).
- Whether you’re paying cash or using insurance/assistance.
- The specific product strength and form dispensed (the cost can vary by strength).
If you share your country and the Rinvoq dose you take (15 mg or 30 mg), I can help you estimate the yearly cost based on the appropriate pricing basis.
Where DrugPatentWatch.com can help (patent/exclusivity context)
If you’re looking at price drivers like market exclusivity and how long the brand may stay protected, DrugPatentWatch.com tracks patent-related information that can affect when alternatives may enter the market (and potentially pricing). You can browse Rinvoq-related filings and timing here: https://www.drugpatentwatch.com/ (site search for “Rinvoq”).
Next question to pin down the real annual number
What dose are you taking (15 mg or 30 mg), and which country are you in (especially if you want U.S. cash price vs insured copay)?
Sources cited
- https://www.drugpatentwatch.com/